ES2877678T3 - Método de preparación para un compuesto de pirrolopirimidina quiral - Google Patents
Método de preparación para un compuesto de pirrolopirimidina quiral Download PDFInfo
- Publication number
- ES2877678T3 ES2877678T3 ES17812738T ES17812738T ES2877678T3 ES 2877678 T3 ES2877678 T3 ES 2877678T3 ES 17812738 T ES17812738 T ES 17812738T ES 17812738 T ES17812738 T ES 17812738T ES 2877678 T3 ES2877678 T3 ES 2877678T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- formula
- group
- amino
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C(C=C=N*)=C(C1)C(C#N)=SCN)=N[C@@]1N Chemical compound CC(C(C=C=N*)=C(C1)C(C#N)=SCN)=N[C@@]1N 0.000 description 8
- DJABJBMSFWLCMJ-GFCCVEGCSA-N C=CN([C@H](CC#N)C1CCCC1)C=C Chemical compound C=CN([C@H](CC#N)C1CCCC1)C=C DJABJBMSFWLCMJ-GFCCVEGCSA-N 0.000 description 1
- PNVDRQFAIDRIQG-GVHYBUMESA-N N[C@H](CC(N)O)C1CCCC1 Chemical compound N[C@H](CC(N)O)C1CCCC1 PNVDRQFAIDRIQG-GVHYBUMESA-N 0.000 description 1
- WFMWIYMCLOLEQT-UHFFFAOYSA-N O=C(C1)NNC1C1CCCC1 Chemical compound O=C(C1)NNC1C1CCCC1 WFMWIYMCLOLEQT-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610432126.5A CN107513069A (zh) | 2016-06-16 | 2016-06-16 | 手性吡咯并嘧啶化合物的制备方法 |
| PCT/CN2017/088421 WO2017215627A1 (zh) | 2016-06-16 | 2017-06-15 | 手性吡咯并嘧啶化合物的制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2877678T3 true ES2877678T3 (es) | 2021-11-17 |
Family
ID=60663390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES17812738T Active ES2877678T3 (es) | 2016-06-16 | 2017-06-15 | Método de preparación para un compuesto de pirrolopirimidina quiral |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10766901B2 (enExample) |
| EP (1) | EP3473625B1 (enExample) |
| JP (1) | JP6998896B2 (enExample) |
| CN (3) | CN107513069A (enExample) |
| ES (1) | ES2877678T3 (enExample) |
| WO (1) | WO2017215627A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022515272A (ja) * | 2018-12-24 | 2022-02-17 | チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド | ピロロピリミジン化合物の治療的使用およびその固形医薬組成物 |
| CN114981272B (zh) * | 2020-03-09 | 2025-04-11 | 正大天晴药业集团股份有限公司 | 吡咯并嘧啶化合物的治疗噬血细胞综合征的用途 |
| AU2021329301A1 (en) | 2020-08-18 | 2023-04-13 | Incyte Corporation | Process and intermediates for preparing a JAK1 inhibitor |
| KR20230096973A (ko) | 2020-08-18 | 2023-06-30 | 인사이트 코포레이션 | Jak 저해제를 제조하기 위한 방법 및 중간체 |
| CN114085224A (zh) * | 2020-08-25 | 2022-02-25 | 北京普祺医药科技有限公司 | 一种吡咯并嘧啶化合物的制备方法 |
| EP4361152A4 (en) | 2021-06-21 | 2025-05-28 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Use of a pyrrholopyrimidine compound and pharmaceutical composition thereof for the treatment of chronic graft-versus-host disease |
| CN118317946A (zh) | 2021-07-12 | 2024-07-09 | 因赛特公司 | 用于制备巴瑞替尼的方法和中间体 |
| WO2023179547A1 (zh) | 2022-03-21 | 2023-09-28 | 正大天晴药业集团股份有限公司 | 吡咯并嘧啶化合物治疗中高危骨髓纤维化的用途 |
| CN119585277A (zh) | 2022-08-04 | 2025-03-07 | 正大天晴药业集团股份有限公司 | 吡咯并嘧啶化合物治疗急性移植物抗宿主病的用途 |
| US20250215003A1 (en) * | 2022-08-22 | 2025-07-03 | Granules India Limited | An improved process for the preparation of ruxolitinib |
| CN120882718A (zh) * | 2023-03-17 | 2025-10-31 | 北京普祺医药科技股份有限公司 | 吡咯并嘧啶化合物或其可药用盐的制备方法 |
| WO2024230727A1 (zh) * | 2023-05-09 | 2024-11-14 | 正大天晴药业集团股份有限公司 | 一种吡咯并[2,3-c]吡啶酮化合物的联用药物组合物及其用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5616499A (en) * | 1979-07-19 | 1981-02-17 | Yamasa Shoyu Co Ltd | 6-c-purine nucleoside derivative and its preparation |
| JPS5841897A (ja) * | 1981-09-04 | 1983-03-11 | Yamasa Shoyu Co Ltd | ６−（４−ピラゾリル）プリンリボヌクレオシド誘導体およびその製造法 |
| PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
| US20050008640A1 (en) | 2003-04-23 | 2005-01-13 | Wendy Waegell | Method of treating transplant rejection |
| DK3184526T3 (en) | 2005-12-13 | 2019-01-14 | Incyte Holdings Corp | PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR |
| JOP20190231A1 (ar) * | 2009-01-15 | 2017-06-16 | Incyte Corp | طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به |
| WO2011028685A1 (en) | 2009-09-01 | 2011-03-10 | Incyte Corporation | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
| CN103848810A (zh) | 2012-11-30 | 2014-06-11 | 北京赛林泰医药技术有限公司 | 鲁顿酪氨酸激酶抑制剂 |
| CN103739607A (zh) * | 2014-01-22 | 2014-04-23 | 无锡方圆环球显示技术股份有限公司 | 一种基于三并咔唑多臂结构红光材料及其制备方法与应用 |
| WO2015187470A1 (en) * | 2014-06-04 | 2015-12-10 | Merck Sharp & Dohme Corp. | Imidazo-pyrazine derivatives useful as soluble guanylate cyclase activators |
| CN105218548A (zh) | 2014-06-09 | 2016-01-06 | 上海海和药物研究开发有限公司 | 一种新型杂环化合物及其制备方法和作为激酶抑制剂的用途 |
| CN105315286B (zh) * | 2014-07-30 | 2018-08-17 | 连云港润众制药有限公司 | 西格列汀的制备 |
| CN105777754B (zh) * | 2014-12-16 | 2019-07-26 | 北京赛林泰医药技术有限公司 | 吡咯并嘧啶化合物 |
| CN107759600A (zh) | 2016-06-16 | 2018-03-06 | 正大天晴药业集团股份有限公司 | 作为jak抑制剂的吡咯并嘧啶化合物的结晶 |
-
2016
- 2016-06-16 CN CN201610432126.5A patent/CN107513069A/zh active Pending
-
2017
- 2017-06-15 CN CN202010744086.4A patent/CN111875607B/zh active Active
- 2017-06-15 ES ES17812738T patent/ES2877678T3/es active Active
- 2017-06-15 US US16/309,882 patent/US10766901B2/en active Active
- 2017-06-15 EP EP17812738.7A patent/EP3473625B1/en active Active
- 2017-06-15 WO PCT/CN2017/088421 patent/WO2017215627A1/zh not_active Ceased
- 2017-06-15 JP JP2018565715A patent/JP6998896B2/ja active Active
- 2017-06-15 CN CN201780037151.6A patent/CN109311892B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2017215627A1 (zh) | 2017-12-21 |
| JP2019523772A (ja) | 2019-08-29 |
| CN107513069A (zh) | 2017-12-26 |
| EP3473625A1 (en) | 2019-04-24 |
| CN109311892A (zh) | 2019-02-05 |
| CN111875607B (zh) | 2021-12-03 |
| US20190211021A1 (en) | 2019-07-11 |
| JP6998896B2 (ja) | 2022-02-04 |
| CN109311892B (zh) | 2020-09-04 |
| EP3473625B1 (en) | 2021-06-02 |
| US10766901B2 (en) | 2020-09-08 |
| EP3473625A4 (en) | 2020-02-19 |
| CN111875607A (zh) | 2020-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2877678T3 (es) | Método de preparación para un compuesto de pirrolopirimidina quiral | |
| CN108699063B (zh) | 一种芦可替尼的合成工艺 | |
| KR102236232B1 (ko) | Jak 저해제를 제조하기 위한 방법 및 중간생성물 | |
| JP7012668B2 (ja) | ジヒドロピリミジニルベンズアゼピンジカルボキサミド化合物 | |
| ES2912469T3 (es) | Procesos de elaboración de (1-(3-fluoro-2-(trifluorometilo)isonicotinil)piperidina-4-ona) | |
| ES2750791T3 (es) | Derivados de indolizina como inhibidores de fosfoinositido 3-quinasas | |
| EP3768272B1 (en) | Jak inhibitors | |
| KR20120084622A (ko) | 시타글립틴의 중간체 제조방법 | |
| KR20230096973A (ko) | Jak 저해제를 제조하기 위한 방법 및 중간체 | |
| AU2021373162B2 (en) | Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof | |
| EP3911326A1 (en) | Bruton's tyrosine kinase inhibitors | |
| WO2014129596A1 (ja) | 三環性化合物の製造方法及び当該製造方法により得ることができる三環性化合物 | |
| CN117645598A (zh) | 氮杂二并多元稠环化合物及其药物组合物和应用 | |
| AU2023255396A1 (en) | Compounds active towards bromodomains | |
| BR122025013614A2 (pt) | Processo para preparar um inibidor de jak, seus intermediários e formas cristalinas | |
| TW202246261A (zh) | 作為抗癌劑的化合物 | |
| CN103965198A (zh) | 替卡格雷的中间体及其制备方法以及利用该中间体制备替卡格雷的方法 | |
| HK40009482B (en) | Processes and intermediates for making a jak inhibitor | |
| HK40009482A (en) | Processes and intermediates for making a jak inhibitor |